TD
Translational Development Acquisition Corp. Warrants (TDACW)
NASDAQ·Technology·General
$1.18
—
Mkt Cap $5.43M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$254.15
Range $172.38 – $298.35
Implied Upside
+21438.1%
Consensus $254.15 vs current $1.18